ESR1 and breast carcinoma: In order to provide novel insights on the action of estrogens toward miRNAs modulation in breast cancer, the ER-negative SkBr3 breast cancer cells and CAFs were treated with 100 nM E2 for 4 h and then analyzed by TaqManTM Array Human MicroRNA.